Want to see SE:OSSD full AI Analyst Report?
Top Page
OssDsign AB
(OSSD)
Select Model
Select Model
Rating:47Neutral
Price Target:
kr4.00
▲(0.50% Upside)
Action:Reiterated
Date:08/09/26
The score is primarily held back by persistent operating losses and ongoing negative operating/free cash flow, alongside stalled recent revenue growth. Offsetting these risks are very strong gross margins and a conservatively levered balance sheet, while technicals remain weak versus longer-term moving averages and valuation is difficult to support due to negative earnings and no indicated dividend.
Positive Factors
Very high gross margins
Sustained ~95%+ gross margins indicate strong product economics and pricing power in the device business. This durable margin buffer means incremental revenue can flow to operating profit once fixed operating costs are controlled, improving long-term profitability potential.
Negative Factors
Persistent cash burn
Consistent negative operating and free cash flow indicate the company is consuming cash to fund operations and growth. Over 2–6 months this reduces runway and forces reliance on external financing or equity, which can dilute shareholders or constrain investments.
Read all positive and negative factors
Positive Factors
Negative Factors
Very high gross margins
Sustained ~95%+ gross margins indicate strong product economics and pricing power in the device business. This durable margin buffer means incremental revenue can flow to operating profit once fixed operating costs are controlled, improving long-term profitability potential.
Read all positive factors
OssDsign AB (OSSD) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr473.48M
Dividend YieldN/A
Average Volume (3M)297.02K
Price to Earnings (P/E)―
Beta (1Y)-0.47
Revenue Growth13.96%
EPS Growth20.18%
CountrySE
Employees35
SectorGeneral
Sector StrengthN/A
IndustryMedical - Devices
Share Statistics
EPS (TTM)-0.45
Shares Outstanding110,625,916
10 Day Avg. Volume325,245
30 Day Avg. Volume297,022
Financial Highlights & Ratios
PEG Ratio3.08
Price to Book (P/B)4.04
Price to Sales (P/S)6.95
P/FCF Ratio-17.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.46
Revenue Forecast (FY)kr168.13M
OssDsign AB Business Overview & Revenue Model
OssDsign AB Financial Statement Overview
Summary
Income Statement
42
Neutral
Balance Sheet
78
Positive
Cash Flow
33
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 172.54M | 180.16M | 133.94M | 112.16M | 56.98M | 31.73M |
| Gross Profit | 164.37M | 173.47M | 127.75M | 83.64M | 45.13M | 20.84M |
| EBITDA | -47.30M | -44.30M | -45.31M | -122.02M | -89.41M | -79.97M |
| Net Income | -47.88M | -50.99M | -49.66M | -130.49M | -99.39M | -93.92M |
Balance Sheet | ||||||
| Total Assets | 377.50M | 397.87M | 307.42M | 356.39M | 339.50M | 343.99M |
| Cash, Cash Equivalents and Short-Term Investments | 170.48M | 191.35M | 100.86M | 165.94M | 124.65M | 151.37M |
| Total Debt | 1.16M | 1.37M | 1.97M | 3.15M | 13.60M | 14.13M |
| Total Liabilities | 78.64M | 87.84M | 93.36M | 105.26M | 91.39M | 81.26M |
| Stockholders Equity | 298.87M | 310.03M | 214.06M | 251.13M | 248.11M | 262.72M |
Cash Flow | ||||||
| Free Cash Flow | -67.92M | -71.43M | -63.04M | -94.03M | -89.36M | -89.84M |
| Operating Cash Flow | -53.03M | -64.03M | -62.38M | -93.91M | -89.23M | -89.78M |
| Investing Cash Flow | -12.11M | -7.40M | -657.00K | -124.00K | -129.00K | -51.85M |
| Financing Cash Flow | 158.51M | 163.18M | -2.46M | 135.40M | 61.84M | 243.43M |
OssDsign AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | kr1.24B | 24.84 | 14.08% | 0.26% | -0.27% | 93.40% | |
59 Neutral | kr1.12B | -102.41 | -2.58% | ― | 28.39% | -141.02% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | kr583.48M | -69.38 | -2.84% | ― | -13.72% | 52.47% | |
50 Neutral | kr581.70M | -5.21 | -37.43% | ― | 27.40% | 26.07% | |
47 Neutral | kr473.48M | -9.46 | ― | ― | 13.96% | 20.18% | |
45 Neutral | kr973.50M | -27.42 | -3.99% | ― | -0.34% | 29.54% |
* General Sector Average
SE:OSSD
OssDsign AB
4.14
-10.55
-71.83%
SE:PAX
Paxman AB
48.10
-28.30
-37.04%
SE:SEZI
Senzime AB
3.84
-2.97
-43.69%
SE:BACTI.B
Bactiguard Holding AB
15.80
-13.10
-45.33%
SE:CRAD.B
C-Rad AB Class B
35.60
1.70
5.03%
SE:SEDANA
Sedana Medical AB
10.68
-6.00
-35.97%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.